1,240
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Berberine decreases S100B generation to regulate gut vascular barrier permeability in mice with burn injury

, , , , &
Pages 53-61 | Received 24 Dec 2022, Accepted 01 Dec 2023, Published online: 18 Dec 2023

References

  • Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. 2001. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 48(6):1255–1260. discussion 1258-1260. doi: 10.1227/00006123-200106000-00012.
  • Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D, Asnicar F, et al. 2021. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 39(5):708–724 e711. doi: 10.1016/j.ccell.2021.03.004.
  • Chandirasegaran G, Elanchezhiyan C, Ghosh K, Sethupathy S. 2017. Berberine chloride ameliorates oxidative stress, inflammation and apoptosis in the pancreas of Streptozotocin induced diabetic rats. Biomed Pharmacother. 95:175–185. doi: 10.1016/j.biopha.2017.08.040.
  • Chao G, Ye F, Yuan Y, Zhang S. 2020. Berberine ameliorates non-steroidal anti-inflammatory drugs-induced intestinal injury by the repair of enteric nervous system. Fundam Clin Pharmacol. 34(2):238–248. doi: 10.1111/fcp.12509.
  • Chen DP, Xiong YJ, Lv BC, Liu FF, Wang L, Tang ZY, Lin Y. 2013. Effects of berberine on rat jejunal motility. J Pharm Pharmacol. 65(5):734–744. doi: 10.1111/jphp.12026.
  • Ciccia F, Guggino G, Rizzo A, Alessandro R, Luchetti MM, Milling S, Saieva L, Cypers H, Stampone T, Di Benedetto P, et al. 2017. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis. 76(6):1123–1132. doi: 10.1136/annrheumdis-2016-210000.
  • Cirillo C, Sarnelli G, Esposito G, Turco F, Steardo L, Cuomo R. 2011. S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. World J Gastroenterol. 17(10):1261–1266. doi: 10.3748/wjg.v17.i10.1261.
  • Costa DVS, Moura-Neto V, Bolick DT, Guerrant RL, Fawad JA, Shin JH, Medeiros P, Ledwaba SE, Kolling GL, Martins CS, et al. 2021. S100B inhibition attenuates intestinal damage and diarrhea severity during Clostridioides difficile infection by modulating inflammatory response. Front Cell Infect Microbiol. 11:739874. doi: 10.3389/fcimb.2021.739874.
  • Costantini TW, Bansal V, Krzyzaniak M, Putnam JG, Peterson CY, Loomis WH, Wolf P, Baird A, Eliceiri BP, Coimbra R. 2010. Vagal nerve stimulation protects against burn-induced intestinal injury through activation of enteric glia cells. Am J Physiol Gastrointest Liver Physiol. 299(6):G1308–1318. doi: 10.1152/ajpgi.00156.2010.
  • Costantini TW, Coimbra R, Weaver JL, Eliceiri BP. 2022. Precision targeting of the vagal anti-inflammatory pathway attenuates the systemic inflammatory response to burn injury. J Trauma Acute Care Surg. 92(2):323–329. doi: 10.1097/TA.0000000000003470.
  • Costantini TW, Loomis WH, Putnam JG, Kroll L, Eliceiri BP, Baird A, Bansal V, Coimbra R. 2009. Pentoxifylline modulates intestinal tight junction signalling after burn injury: effects on myosin light chain kinase. J Trauma. 66(1):17–24. discussion 24-15. doi: 10.1097/TA.0b013e318191bb1f.
  • Dudek SM, Muñoz NM, Desai A, Osan CM, Meliton AY, Leff AR. 2011. Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. Am J Respir Cell Mol Biol. 44(3):361–368. doi: 10.1165/rcmb.2009-0446OC.
  • Earley ZM, Akhtar S, Green SJ, Naqib A, Khan O, Cannon AR, Hammer AM, Morris NL, Li X, Eberhardt JM, et al. 2015. Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation. PLOS One. 10(7):e0129996. doi: 10.1371/journal.pone.0129996.
  • Esposito G, Capoccia E, Turco F, Palumbo I, Lu J, Steardo A, Cuomo R, Sarnelli G, Steardo L. 2014. Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-alpha activation. Gut. 63(8):1300–1312. doi: 10.1136/gutjnl-2013-305005.
  • Feng AW, Gao W, Zhou GR, Yu R, Li N, Huang XL, Li QR, Li JS. 2012. Berberine ameliorates COX-2 expression in rat small intestinal mucosa partially through PPARgamma pathway during acute endotoxemia. Int Immunopharmacol. 12(1):182–188. doi: 10.1016/j.intimp.2011.11.009.
  • Feng AW, Yu C, Mao Q, Li N, Li QR, Li JS. 2011. Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia. Fitoterapia. 82(7):976–982. doi: 10.1016/j.fitote.2011.05.013.
  • Feng Y, Huang Y, Wang Y, Wang P, Wang F. 2019. Severe burn injury alters intestinal microbiota composition and impairs intestinal barrier in mice. Burns Trauma. 7(20):1–14.
  • Grander C, Grabherr F, Spadoni I, Enrich B, Oberhuber G, Rescigno M, Tilg H. 2020. The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementation. Gut Microbes. 12(1):1851986. doi: 10.1080/19490976.2020.1851986.
  • Gu L, Li N, Yu W, Gong J, Li Q, Zhu W, Li J. 2013. Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis. Am J Chin Med. 41(6):1297–1312. doi: 10.1142/S0192415X13500870.
  • Günther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF, et al. 2011. Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis. Nature. 477(7364):335–339. doi: 10.1038/nature10400.
  • He Y, Yuan X, Zuo H, Sun Y, Feng A. 2018. Berberine exerts a protective effect on gut-vascular barrier via the modulation of the Wnt/beta-catenin signalling pathway during sepsis. Cell Physiol Biochem. 49(4):1342–1351. doi: 10.1159/000493412.
  • Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A, Waisman A, Brenner O, Haffner R, Gustafsson E, et al. 2004. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol. 173(5):2976–2984. doi: 10.4049/jimmunol.173.5.2976.
  • Kimono D, Sarkar S, Albadrani M, Seth R, Bose D, Mondal A, Li Y, Kar AN, Nagarkatti M, Nagarkatti P, et al. 2019. Dysbiosis-associated enteric glial cell immune-activation and redox imbalance modulate tight junction protein expression in Gulf War illness pathology. Front Physiol. 10:1229. doi: 10.3389/fphys.2019.01229.
  • Koh SX, Lee JK. 2014. S100B as a marker for brain damage and blood-brain barrier disruption following exercise. Sports Med. 44(3):369–385. doi: 10.1007/s40279-013-0119-9.
  • Li H, Fan C, Lu H, Feng C, He P, Yang X, Xiang C, Zuo J, Tang W. 2020. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharm Sin B. 10(3):447–461. doi: 10.1016/j.apsb.2019.08.006.
  • Li X, Wilder-Smith CH, Kan ME, Lu J, Cao Y, Wong RK. 2014. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation. Neuro Endocrinol Lett. 35(1):58–63.
  • Li Y, Zhou J, Qiu J, Huang Z, Wang W, Wu P, Feng A. 2020. Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis. Life Sci. 261:118460. doi: 10.1016/j.lfs.2020.118460.
  • Liu P, Bian Y, Fan Y, Zhong J, Liu Z. 2020. Protective effect of naringin on in vitro gut-vascular barrier disruption of intestinal microvascular endothelial cells induced by TNF-alpha. J Agric Food Chem. 68(1):168–175. doi: 10.1021/acs.jafc.9b06347.
  • Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, Mileti E, Galbiati M, Invernizzi P, Adorini L, et al. 2019. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 71(6):1216–1228. doi: 10.1016/j.jhep.2019.08.005.
  • Ruan Q, Zhao C, Ye Z, Zhang W, Xie Q, Xie W. 2014. Role of phosphoinositide 3 kinase/protein kinase B signal pathway in monocyte-endothelial adhesion induced by serum of rats with electrical burn. Zhonghua Shao Shang Za Zhi. 30:237–242.
  • Rühl A. 2005. Glial cells in the gut. Neurogastroenterology Motil. 17(6):777–790. doi: 10.1111/j.1365-2982.2005.00687.x.
  • Seguella L, Gulbransen BD. 2021. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol. 18(8):571–587. doi: 10.1038/s41575-021-00423-7.
  • Sorribas M, Jakob MO, Yilmaz B, Li H, Stutz D, Noser Y, de Gottardi A, Moghadamrad S, Hassan M, Albillos A, et al. 2019. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. J Hepatol. 71(6):1126–1140. doi: 10.1016/j.jhep.2019.06.017.
  • Spadoni I, Pietrelli A, Pesole G, Rescigno M. 2016. Gene expression profile of endothelial cells during perturbation of the gut vascular barrier. Gut Microbes. 7(6):540–548. doi: 10.1080/19490976.2016.1239681.
  • Spadoni I, Zagato E, Bertocchi A, Paolinelli R, Hot E, Di Sabatino A, Caprioli F, Bottiglieri L, Oldani A, Viale G, et al. 2015. A gut-vascular barrier controls the systemic dissemination of bacteria. Science. 350(6262):830–834. doi: 10.1126/science.aad0135.
  • Tisch N, Mogler C, Stojanovic A, Luck R, Korhonen EA, Ellerkmann A, Adler H, Singhal M, Schermann G, Erkert L, et al. 2022. Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice. EMBO Mol Med. 14(6):e14121. doi: 10.15252/emmm.202114121.
  • von Boyen GBT, Schulte N, Pflüger C, Spaniol U, Hartmann C, Steinkamp M. 2011. Distribution of enteric glia and GDNF during gut inflammation. BMC Gastroenterol. 11(1):3. doi: 10.1186/1471-230X-11-3.
  • Xia J, Zhang J, Wang L, Liu H, Wang J, Liu J, Liu Z, Zhu Y, Xu Y, Yang W, et al. 2021. Non-apoptotic function of caspase-8 confers prostate cancer enzalutamide resistance via NF-kappaB activation. Cell Death Dis. 12(9):833. doi: 10.1038/s41419-021-04126-4.
  • Xiao L, Hu L, Chu H, Chen L, Yan J, Wang W, Yang X, Zhu Q, Du F, Song Y, et al. 2022. Retrorsine cooperates with gut microbiota to promote hepatic sinusoidal obstruction syndrome by disrupting the gut barrier. J Clin Transl Hepatol. 10(6):1086–1098. doi: 10.14218/JCTH.2021.00398.
  • Xu JH, Liu XZ, Pan W, Zou DJ. 2017. Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Mol Med Rep. 15(5):2765–2787. doi: 10.3892/mmr.2017.6321.
  • Yu ZC, Cen YX, Wu BH, Wei C, Xiong F, Li DF, Liu TT, Luo MH, Guo LL, Li YX, et al. 2019. Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats. World J Gastroenterol. 25(29):3956–3971. doi: 10.3748/wjg.v25.i29.3956.
  • Zang QS, Maass DL, Wigginton JG, Barber RC, Martinez B, Idris AH, Horton JW, Nwariaku FE. 2010. Burn serum causes a CD14-dependent mitochondrial damage in primary cardiomyocytes. Am J Physiol Heart Circ Physiol. 298(6):H1951–1958. doi: 10.1152/ajpheart.00927.2009.
  • Zhang JP, Ying X, Chen Y, Yang ZC, Huang YS. 2008. Inhibition of p38 MAP kinase improves survival of cardiac myocytes with hypoxia and burn serum challenge. Burns. 34(2):220–227. doi: 10.1016/j.burns.2007.03.009.
  • Zhang L, Jiang Y, Deng S, Mo Y, Huang Y, Li W, Ge C, Ren X, Zhang H, Zhang X, et al. 2021. S100B/RAGE/Ceramide signalling pathway is involved in sepsis-associated encephalopathy. Life Sci. 277:119490. doi: 10.1016/j.lfs.2021.119490.
  • Ziegler TR, Smith RJ, O’Dwyer ST, Demling RH, Wilmore DW. 1988. Increased intestinal permeability associated with infection in burn patients. Arch Surg. 123(11):1313–1319. doi: 10.1001/archsurg.1988.01400350027003.
  • Zou Z, Li L, Li Q, Zhao P, Zhang K, Liu C, Cai D, Maegele M, Gu Z, Huang Q. 2022. The role of S100B/RAGE-enhanced ADAM17 activation in endothelial glycocalyx shedding after traumatic brain injury. J Neuroinflammation. 19(1):46. doi: 10.1186/s12974-022-02412-2.